Brief: Cassava Sciences Provides A Business Update

Filana Therapeutics

07/01/2025 22:49

Jan 7 (Reuters) - Cassava Sciences Inc  SAVA.O :
    * CASSAVA SCIENCES PROVIDES A BUSINESS UPDATE
    * CASSAVA SCIENCES INC: IMPLEMENTING COST CURTAILMENT
INCLUDING A
WORKFORCE REDUCTION OF APPROXIMATELY 33%
    * CASSAVA SCIENCES INC: ESTIMATES THAT IT WILL INCUR
APPROXIMATELY
$0.4 MILLION OF ONE-TIME COSTS IN Q1 2025 RELATED TO WORKFORCE
REDUCTION
    * CASSAVA SCIENCES INC: IN FINAL STAGES OF DISCONTINUING
REFOCUS-ALZ STUDY
    * CASSAVA- TOPLINE DATA FROM PHASE 3 REFOCUS-ALZ STUDY OF
SIMUFILAM IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMER'S DISEASE
EXPECTED LATE Q1/EARLY Q2 2025

Source text:  ID:nGNX8hgxHK 
Further company coverage:  SAVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))